Home » Transforming drug, med-tech R&D with AI

Transforming drug, med-tech R&D with AI

Published August 2019

Deals analysis

Transforming R&D and health care with artificial intelligence

Biopharmas move into deep waters of massive data, high R&D potential

AI propels med tech into new partnerships, new possibilities

Global regulatory impacts

U.S. AI med-tech regs in development ‘not for the faint of heart’

FDA looks to AI to streamline drug development and approval process

American AI Initiative

China on the cusp of regulating AI-based devices

Japan to develop assessment system to speed up AI development

Australia: No plans to regulate AI, machine learning via separate pathway

South Korea’s insurance, personal information law slows use of AI devices

India lags in regulating AI as development proceeds

The scientific black box – changing skillsets – intellectual property

AI’s superpowers lie in questions, not answers

Across the great (skills) divide

Supreme Court’s Alice decision leaves drug, device firms in AI wonderland

Research hospitals push AI beyond pattern recognition

Follow the money

What if artificial intelligence invents something?

Digital health financings sees continued momentum

VC meeting at the crossroads of biopharma R&D, computation

Clinical trials integration

AI starting to improve efficiency in med-tech clinical trials

AI in the clinic opens new vistas for biopharma investigators

AI in Asia-Pacific

Putting the AI in ASEAN

AI is expected to drive health care effectiveness, increase jobs in Australia

Challenges, opportunities and ethics

Ethical issues trailing AI are writ large in health care

At the crossroads of people and technology

Popular Stories

South Korea approves first four COVID-19 test kits under urgent-use license
BioWorld
HONG KONG – South Korea’s Ministry of Food and Drug Safety (MFDS) recently granted the first urgent-use licenses to four COVID-19 novel coronavirus diagnostic...
CHF Solutions looks to bring its tech to help COVID-19 patients
BioWorld MedTech
As the COVID-19 outbreak continues to dominate the news, an increasing number of companies have come forward to help. For its part, CHF Solutions Inc., of Eden...
Two South Korean COVID-19 kits look overseas, seek FDA approval
BioWorld MedTech
HONG KONG – As the number of COVID-19 confirmed cases and deaths continue to rise globally, South Korea’s focus on testing has attracted international attention....
Sihuan starts clinical trial of Ebola drug favipiravir for COVID-19
BioWorld Asia
BEIJING – Beijing-based Sihuan Pharmaceutical Holdings Group Ltd. said it has initiated clinical trials of broad-spectrum antiviral favipiravir to treat COVID-19....
Mallinckrodt to submit IND to FDA for inhaled nitric oxide to treat COVID-19 respiratory distress
BioWorld
Mallinckrodt plc is engaging with the U.S. FDA, NIH and the Biomedical Advanced Research and Development Authority to address the potential use of its INOmax...

cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.